<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04001426</url>
  </required_header>
  <id_info>
    <org_study_id>CIP-003</org_study_id>
    <nct_id>NCT04001426</nct_id>
  </id_info>
  <brief_title>Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence Device</brief_title>
  <official_title>Pilot Phase for an Acute Evaluation of a Non-Implantable Electrical Continence Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>FemPulse Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>FemPulse Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this feasibility clinical investigation is to investigate a new medical device
      treatment for Overactive Bladder (OAB) in women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The FemPulse System is a vaginal ring intended to provide mild electrical stimulation to
      nerves that regulate bladder function. It is believed that stimulation of these nerves may
      help relieve the symptoms of OAB.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 4, 2019</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Subjects will wear a device and will be monitored non-invasively during activation of the device.</intervention_model_description>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Autonomic nervous system response</measure>
    <time_frame>Up to 6 hours</time_frame>
    <description>The Quantitative Sudomotor Axon Reflex Test (QSART) will be used to detect changes in autonomic nervous system activity during device activation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evoked Potential response</measure>
    <time_frame>Up to 6 hours</time_frame>
    <description>Surface electrodes will be used to detect whether evoked potentials are generated during device activation</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">2</enrollment>
  <condition>Urinary Bladder, Overactive</condition>
  <arm_group>
    <arm_group_label>Monitoring during activation of the FemPulse System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will undergo non-invasive monitoring during activation of the FemPulse System.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>The FemPulse System</intervention_name>
    <description>Non-invasive monitoring during activation of the FemPulse System</description>
    <arm_group_label>Monitoring during activation of the FemPulse System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Normal healthy women â‰¥ 21 years old

          -  Using contraception if of reproductive age

        Exclusion Criteria:

          -  Pregnant, recently pregnant or actively trying to conceive

          -  Prior hysterectomy

          -  Current or recent urinary tract or vaginal infection
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hennepin Healthcare</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>June 24, 2019</study_first_submitted>
  <study_first_submitted_qc>June 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2019</study_first_posted>
  <last_update_submitted>November 6, 2019</last_update_submitted>
  <last_update_submitted_qc>November 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Overactive Bladder</keyword>
  <keyword>Women</keyword>
  <keyword>Neuromodulation</keyword>
  <keyword>Bioelectronic Medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder, Overactive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

